Reflections from World AMR Congress

In September, the NovaBiotics team were in Washington for World AMR Congress - our CEO Deborah O’Neil reflects on the conference here -

The discussion throughout the conference confirmed that this sector of the industry is in ”violent agreement” on the position towards antimicrobial resistance and the need for new drugs to address the looming global public health crisis. There is a lot of frustration with the broken economic model for antibiotics. The view from many is that innovative efforts are not recognised or rewarded simply because antibiotics are not seen as the lifesaving drugs and as such they are not priced competitively, removing the incentive for development. New models of pricing are urgently needed”.